CAI fund manager activity
Caris Life Sciences, Inc · Nasdaq. Reported by 3 tracked fund managers in their 13F filings, Q2 2025 to Q2 2026.
Q2 2026
| Manager | Activity | Shares | Value | % of portfolio | Filed |
|---|
| Philippe Laffont - Coatue Management | No change | 9,819,992 | $174,992,258 | 0.36% | Aug 14, 2026 |
| Stanley Druckenmiller - Duquesne Family Office | No change | 1,894,450 | $33,759,000 | 0.78% | Aug 14, 2026 |
| Joel Greenblatt - Gotham Asset Management | Trimmed | 89,535 | $1,595,514 | 0.00% | Aug 14, 2026 |
Q1 2026
| Manager | Activity | Shares | Value | % of portfolio | Filed |
|---|
| Philippe Laffont - Coatue Management | No change | 9,819,992 | $175,581,457 | 0.60% | May 15, 2026 |
| Stanley Druckenmiller - Duquesne Family Office | New | 1,894,450 | $33,873,000 | 1.15% | May 15, 2026 |
| Joel Greenblatt - Gotham Asset Management | Added | 744,426 | $13,310,337 | 0.04% | May 15, 2026 |
Older quarters